First and only Nice-recommended medicine could ‘alleviate misery’ of condition in England and Wales
NHS health advisers have approved the first treatment for acute migraine in a decision that promises to bring relief to about 13,000 people.
The National Institute of Health and Clinical Excellence (Nice) has recommended a drug called rimegepant, also known as Vydura, which is made by Pfizer.